{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:22:56Z","timestamp":1768015376872,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00417-018-3958-0","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T19:34:48Z","timestamp":1521228888000},"page":"927-933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients"],"prefix":"10.1007","volume":"256","author":[{"given":"Efrat","family":"Fleissig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mor","family":"Pavlovksy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Loewenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinah","family":"Zur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadas","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shay","family":"Keren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafna","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrat","family":"Bar-Ilan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaella","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"3958_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0190-9622(98)70194-X","volume":"38","author":"SO Kovacs","year":"1998","unstructured":"Kovacs SO (1998) Vitiligo. J Am Acad Dermatol 38:647\u2013666","journal-title":"J Am Acad Dermatol"},{"key":"3958_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2165\/00128071-200102030-00006","volume":"2","author":"MD Njoo","year":"2001","unstructured":"Njoo MD, Westerhof W (2001) Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2:167\u2013181","journal-title":"Am J Clin Dermatol"},{"key":"3958_CR3","unstructured":"Birlea SA, Spritz RA, Norris DA (2012) Vitiligo. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K (eds) Fitzpatrick\u2019s dermatology in general medicine, 8th edn. New York, pp 792\u2013803"},{"key":"3958_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0190-9622(86)70136-9","volume":"15","author":"CL Cowan Jr","year":"1986","unstructured":"Cowan CL Jr, Halder RM, Grimes PE, Chakrabarti SG, Kenney JA Jr (1986) Ocular disturbances in vitiligo. J Am Acad Dermatol 15:17\u201324","journal-title":"J Am Acad Dermatol"},{"key":"3958_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/bjo.67.3.153","volume":"67","author":"DM Albert","year":"1983","unstructured":"Albert DM, Wagoner MD, Pruett RC, Nordlund JJ, Lerner AB (1983) Vitiligo and disorders of the retinal pigment epithelium. Br J Ophthalmol 67:153\u2013156","journal-title":"Br J Ophthalmol"},{"key":"3958_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/ijd.13031","volume":"55","author":"R Karadag","year":"2016","unstructured":"Karadag R, Esmer O, Karadag AS, Bilgili SG, Cakici O, Demircan YT, Bayramlar H (2016) Evaluation of ocular findings in patients with vitiligo. Int J Dermatol 55:351\u2013355","journal-title":"Int J Dermatol"},{"key":"3958_CR7","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0161-6420(79)35413-6","volume":"86","author":"DM Albert","year":"1979","unstructured":"Albert DM, Nordlund JJ, Lerner AB (1979) Ocular abnormalities occurring with vitiligo. Ophthalmology 86:1145\u20131160","journal-title":"Ophthalmology"},{"key":"3958_CR8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1468-3083.2006.01655.x","volume":"20","author":"E Bulbul Baskan","year":"2006","unstructured":"Bulbul Baskan E, Baykara M, Ercan I, Tunali S, Yucel A (2006) Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol 20:829\u2013833","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3958_CR9","first-page":"141","volume":"145","author":"M Perossini","year":"2010","unstructured":"Perossini M, Turio E, Perossini T, Cei G, Barachini P (2010) Vitiligo: ocular and electrophysiological findings. Ital Dermatol Venereol 145:141\u2013149","journal-title":"Ital Dermatol Venereol"},{"key":"3958_CR10","doi-asserted-by":"publisher","unstructured":"Aydin R, Ozsutcu M, Erdur SK, Dikkaya F, Balevi A, Ozbek M, Senturk F (2017) The assessment of macular electrophysiology and macular morphology in patients with vitiligo. Int Ophthalmol. https:\/\/doi.org\/10.1007\/s10792-017-0452-3","DOI":"10.1007\/s10792-017-0452-3"},{"key":"3958_CR11","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.ophtha.2005.06.011","volume":"112","author":"AD Singh","year":"2005","unstructured":"Singh AD, Kalyani P, Topham A (2005) Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology 112:1784\u20131789","journal-title":"Ophthalmology"},{"key":"3958_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/archopht.116.5.645","volume":"116","author":"P Sumich","year":"1998","unstructured":"Sumich P, Mitchell P, Wang JJ (1998) Choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophthalmol 116:645\u2013650","journal-title":"Arch Ophthalmol"},{"key":"3958_CR13","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.ophtha.2015.06.008","volume":"122","author":"M Qiu","year":"2015","unstructured":"Qiu M, Shields CL (2015) Choroidal nevus in the United States adult population: racial disparities and associated factors in the National Health and Nutrition Examination Survey. Ophthalmology 122:2071\u20132083","journal-title":"Ophthalmology"},{"key":"3958_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/opo.12092","volume":"34","author":"A Gordon-Shaag","year":"2014","unstructured":"Gordon-Shaag A, Barnard S, Millodot M, Gantz L, Chiche G, Vanessa E, Ruth W, Pinchasov R, Gosman Z, Simchi M, Koslowe K, Shneor E (2014) Prevalence of choroidal naevi using scanning laser ophthalmoscope. Ophthalmic Physiol Opt 34:94\u2013101","journal-title":"Ophthalmic Physiol Opt"},{"key":"3958_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","volume":"9","author":"JJ Nordlund","year":"1983","unstructured":"Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB (1983) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9:689\u2013696","journal-title":"J Am Acad Dermatol"},{"key":"3958_CR16","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/jama.1978.03280390079031","volume":"239","author":"AB Lerner","year":"1978","unstructured":"Lerner AB, Nordlund JJ (1978) Vitiligo: what is it? Is it important? JAMA 239:1183\u20131187","journal-title":"JAMA"},{"key":"3958_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/archderm.1977.01640040029001","volume":"113","author":"AB Lerner","year":"1977","unstructured":"Lerner AB, Nordlund JJ (1977) Should vitiligo be induced in patients after resection of primary melanoma? Arch Dermatol 113:421","journal-title":"Arch Dermatol"},{"key":"3958_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/archderm.1982.01650130038016","volume":"118","author":"DM Albert","year":"1982","unstructured":"Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB (1982) Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Arch Dermatol 118:34\u201336","journal-title":"Arch Dermatol"},{"key":"3958_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/archophthalmol.2010.132","volume":"128","author":"CL Shields","year":"2010","unstructured":"Shields CL, Maktabi AM, Jahnle E, Mashayekhi A, Lally SE, Shields JA (2010) Halo nevus of the choroid in 150 patients: the 2010 Henry van dyke lecture. Arch Ophthalmol 128:859\u2013864","journal-title":"Arch Ophthalmol"},{"key":"3958_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1468-3083.2012.04504.x","volume":"27","author":"A Patrizi","year":"2013","unstructured":"Patrizi A, Bentivogli M, Raone B, Dondi A, Tabanelli M, Neri I (2013) Association of halo nevus\/I and vitiligo in childhood: a retrospective observational study. J Eur Acad Dermatol Venereol 27:48\u201352","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3958_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","volume":"77","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group (2017) New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 77:1\u201313","journal-title":"J Am Acad Dermatol"},{"key":"3958_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1600-0625.2010.01181.x","volume":"20","author":"EH Kemp","year":"2011","unstructured":"Kemp EH, Emhemad S, Akhtar S, Watson PF, Gawkrodger DJ, Weetman AP (2011) Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Exp Dermatol 20:35\u201340","journal-title":"Exp Dermatol"},{"key":"3958_CR23","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","volume":"139","author":"EH Kemp","year":"1998","unstructured":"Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP (1998) Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol 139:798\u2013805","journal-title":"Br J Dermatol"},{"key":"3958_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2249.1997.4781381.x","volume":"109","author":"EH Kemp","year":"1997","unstructured":"Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP (1997) Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 109:495\u2013500","journal-title":"Clin Exp Immunol"},{"key":"3958_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1046\/j.1365-2249.1996.d01-727.x","volume":"105","author":"E Baharav","year":"1996","unstructured":"Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrud B, Yecheskel G, Youinou P, Fishman P (1996) Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 105:84\u201388","journal-title":"Clin Exp Immunol"},{"key":"3958_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/1346-8138.13520","volume":"44","author":"Y Nakamura","year":"2017","unstructured":"Nakamura Y, Tanaka R, Asami Y, Teramoto Y, Imamura T, Sato S, Maruyama H, Fujisawa Y, Matsuya T, Fujimoto M, Yamamoto A (2017) Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: a multi-institutional retrospective study. J Dermatol 44:117\u2013122","journal-title":"J Dermatol"},{"key":"3958_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0190-9622(96)90718-5","volume":"35","author":"SK Hann","year":"1996","unstructured":"Hann SK, Lee HJ (1996) Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 35:671\u2013674","journal-title":"J Am Acad Dermatol"},{"key":"3958_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ajo.2008.12.008","volume":"147","author":"R Margolis","year":"2009","unstructured":"Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147:811\u2013815","journal-title":"Am J Ophthalmol"},{"key":"3958_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ajo.2009.04.029","volume":"148","author":"T Fujiwara","year":"2009","unstructured":"Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 148:445\u2013450","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-018-3958-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-3958-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-3958-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T02:38:11Z","timestamp":1719887891000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-018-3958-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3958"],"URL":"https:\/\/doi.org\/10.1007\/s00417-018-3958-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,16]]},"assertion":[{"value":"19 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Tel Aviv Sourasky Medical Center) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}